Advanced in Wiskott-Aldrich Syndrome

Dr. Donald B. Kohn

Pediatric Hematology Oncology
4650 W Sunset Blvd, Ms# 62, 
Los Angeles, CA 
Clinical Trials:Currently Recruiting for 1 Trial
42 Years of Experience
Advanced in Wiskott-Aldrich Syndrome
4650 W Sunset Blvd, Ms# 62, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Donald Kohn is a Pediatric Hematologist Oncology provider in Los Angeles, California. Dr. Kohn has been practicing medicine for over 42 years and is rated as an Advanced provider by MediFind in the treatment of Wiskott-Aldrich Syndrome. His top areas of expertise are Severe Combined Immunodeficiency (SCID), Adenosine Deaminase Deficiency, X-Linked Severe Combined Immunodeficiency, Hemoglobinopathy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 197 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Wiskott-Aldrich Syndrome.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Optima Health
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

4650 W Sunset Blvd, Ms# 62, Los Angeles, CA 90027

Additional Areas of Focus

Dr. Kohn has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease
Transplantation of CRISPRCas9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease
Enrollment Status: Recruiting
Publish Date: September 20, 2024
Intervention Type: Drug
Study Drug: CRISPR_SCD001
Study Phase: Phase 1/Phase 2
Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector
Clinical Research Study of Autologous Stem Cell Transplantation for Sickle Cell Disease (SCD) Using Peripheral Blood CD34+ Cells Modified With the Lenti/G-βAS3-FB Lentiviral Vector
Enrollment Status: Completed
Publish Date: December 17, 2025
Intervention Type: Biological
Study Drug: ?AS3-FB vector transduced peripheral blood CD34+ cells
Study Phase: Phase 1/Phase 2
A Two-Part, Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
A Two-Part, Phase I/II, Non Randomized, Multicenter, Open-Label Study of G1XCGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease
Enrollment Status: Completed
Publish Date: May 02, 2025
Intervention Type: Biological
Study Drug: Lentiviral G1XCGD Gene Therapy
Study Phase: Phase 1/Phase 2
Multi-site Phase I/II Trial Evaluating the Treatment of SCID-X1 Patients With Retrovirus-mediated Gene Transfer
Multi-site Phase I/II Trial Evaluating the Treatment of SCID-X1 Patients With Retrovirus-mediated Gene Transfer
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Biological
Study Drugs: Busulfan, Bone Marrow Cell Infusion
Study Phase: Phase 1/Phase 2
Efficacy and Safety of Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency Due to ADA Deficiency
Efficacy and Safety of Cryopreserved Formulation of Autologous CD34+ Hematopoietic Stem Cells Transduced Ex Vivo With Elongation Factor 1 Alpha Shortened (EFS) Lentiviral Vector Encoding for Human ADA Gene in Subjects With Severe Combined Immunodeficiency Due to ADA Deficiency
Enrollment Status: Completed
Publish Date: August 03, 2022
Intervention Type: Genetic, Drug
Study Phase: Phase 1/Phase 2
A Single Arm, Open Label Clinical Study to Enable Process Validation of Commercial Grade Ex Vivo Hematopoietic Stem Cell Gene Therapy (OTL-101) in Subjects With Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)
A Single Arm, Open Label Clinical Study to Enable Process Validation of Commercial Grade Ex Vivo Hematopoietic Stem Cell Gene Therapy (OTL-101) in Subjects With Severe Combined Immunodeficiency Due to Adenosine Deaminase Deficiency (ADA-SCID)
Enrollment Status: Withdrawn
Publish Date: August 03, 2022
Intervention Type: Biological
Study Phase: Phase 2/Phase 3
View 5 Less Clinical Trials

197 Total Publications

Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.
Prime Editing for p47phox-Deficient Chronic Granulomatous Disease.
Journal: The New England journal of medicine
Published: December 08, 2025
Similar Doctors
Distinguished in Wiskott-Aldrich Syndrome
Dr. David K. Buchbinder
Pediatric Hematology Oncology
Distinguished in Wiskott-Aldrich Syndrome
Dr. David K. Buchbinder
Pediatric Hematology Oncology

Childrens Hospital Of Orange County

1201 W La Veta Ave, 
Orange, CA 
 (32.7 miles away)
888-770-2462
Languages Spoken:
English
See accepted insurances

David Buchbinder is a Pediatric Hematologist Oncology provider in Orange, California. Dr. Buchbinder is rated as a Distinguished provider by MediFind in the treatment of Wiskott-Aldrich Syndrome. His top areas of expertise are Wiskott-Aldrich Syndrome, Severe Combined Immunodeficiency (SCID), X-Linked Severe Combined Immunodeficiency, Aplastic Anemia, and Bone Marrow Transplant.

Advanced in Wiskott-Aldrich Syndrome
Dr. Neena R. Kapoor
Pediatric Hematology Oncology
Advanced in Wiskott-Aldrich Syndrome
Dr. Neena R. Kapoor
Pediatric Hematology Oncology

Childrens Hospital Los Angeles Medical Group Inc

4650 W Sunset Blvd, 
Los Angeles, CA 
 (0.1 miles away)
323-361-8408
Languages Spoken:
English
See accepted insurances

Neena Kapoor is a Pediatric Hematologist Oncology provider in Los Angeles, California. Dr. Kapoor is rated as a Distinguished provider by MediFind in the treatment of Wiskott-Aldrich Syndrome. Her top areas of expertise are Severe Combined Immunodeficiency (SCID), Chronic Granulomatous Disease, Graft Versus Host Disease (GvHD), Bone Marrow Transplant, and Endoscopy.

Experienced in Wiskott-Aldrich Syndrome
Dr. Yunzu M. Wang
Pediatric Hematology Oncology
Experienced in Wiskott-Aldrich Syndrome
Dr. Yunzu M. Wang
Pediatric Hematology Oncology

City Of Hope Medical Foundation

1500 Duarte Rd, 
Duarte, CA 
 (18.3 miles away)
626-256-4673
Languages Spoken:
English
See accepted insurances

Yunzu Wang is a Pediatric Hematologist Oncology provider in Duarte, California. Dr. Wang is rated as an Advanced provider by MediFind in the treatment of Wiskott-Aldrich Syndrome. Her top areas of expertise are Hemophagocytic Lymphohistiocytosis, Virus Associated Hemophagocytic Syndrome, Chronic Graft Versus Host Disease (cGvHD), Congenital Aplastic Anemia, and Bone Marrow Transplant.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kohn's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile